Clinical Trial Update: Phase I Study of Adenoviral Vector Mediated Gene Transfer for Ornithine Transcarbamylase in Adults With Partial Ornithine Transcarbamylase Deficiency [Phase 1]

View source ↗

Summary

A Phase I study evaluating an adenoviral vector mediated gene transfer for adults with partial ornithine transcarbamylase deficiency has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ornithine Transcarbamylase Deficiency

Drugs mentioned

• Adenoviral vector mediated gene transfer therapy for OTC deficiency

Snippet

Sponsor: University of Pennsylvania | Conditions: Ornithine Transcarbamylase Deficiency Disease | Phase 1 | Status: TERMINATED